CD20 Recombinant Antibody [10F381 (rituximab)] (OAAV00089), Clone: [10F381 rituximab], Rabbit, Monoclonal

Produktübersicht

• Artikelname: CD20 Recombinant Antibody [10F381 (rituximab)] (OAAV00089), Clone: [10F381 rituximab], Rabbit, Monoclonal
• Artikelnummer: ASB-OAAV00555
• Hersteller Artikelnummer: OAAV00555
• Alternativnummer: ASB-OAAV00555-200UG
• Hersteller: Aviva
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: FC
• Spezies Reaktivität: Human, Primate
• Immunogen: Human lymphoblastoid cell line SB.
• Alternative Synonym: B1,B-lymphocyte antigen CD20,B-lymphocyte cell-surface antigen B1,B-lymphocyte surface antigen B1,Bp35,CD20,CD20 antigen,CD20 receptor,CVID5,FMC7,LEU-16,leukocyte surface antigen Leu-16,Membrane-spanning 4-domains subfamily A member 1,membrane-spanning 4

Produktbeschreibung

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [10F381 rituximab]
• Tag: P11836
• NCBI: 931
• Formulierung: PBS with 0.02% Proclin 300.

Anwendungsbeschreibung

• Application Verdünnung: This protein may be involved in the regulation of B-cell activation and proliferation.

Bilder